Monday, January 06, 2025 | 09:05 AM ISTEN Hindi

Home / Health / Maharashtra may procure remdesivir from Bangladesh to treat Covid patients

Maharashtra may procure remdesivir from Bangladesh to treat Covid patients

State government to procure 10,000 vials for Rs 12 crore

testing, private laboratories, labs, vaccines, doctors, nurses, health, coronavirus

Premium

Under World Trade Organisation provisions, lesser developed countries like Bangladesh can produce generic versions of patented drugs without seeking a license

Sohini Das Aneesh Phadnis Mumbai

4 min read Last Updated : Jun 07 2020 | 11:42 AM IST

Maharashtra government on Saturday said that it will procure the repurposed Ebola drug remdesivir to treat critical Covid-19 patients in the state at a price of Rs 12000 per vial. Since the Indian manufacturers of the drug are yet to have the marketing authorisation for the drug and its innovator Gilead is yet to launch in the market, the state government is open to procuring it from Bangladesh.

Maharashtra has registered more than 80,000 cases of Covid-19 and is the worst affected state in the country.

Maharashtra health minister Rajesh Tope said that the state government has decided to procure

Topics : Coronavirus Maharashtra Bangladesh Ebola Indian pharma companies Uddhav Thackeray Maharashtra government World Trade organisation Drug Controller General of India

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in